Viewing Study NCT03491904


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2025-12-25 @ 6:59 PM
Study NCT ID: NCT03491904
Status: COMPLETED
Last Update Posted: 2021-03-03
First Post: 2018-04-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: To Assess the Patients' Ability to Self-Administer Fasinumab
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module